Myomo(MYO) - 2023 Q2 - Earnings Call Transcript

Thanks, Kim. Good afternoon, everyone, and thanks for joining us. As we reported in our earnings press release, we had a very solid quarter with year-over-year growth in revenue and in all of our key operating metrics. More specifically, we continue to increase shipments of our MyoPro device and to build our patient pipeline for future revenue growth, now including Medicare Part B patients. We received the final license payment for our joint venture in China, which has enabled the launch of the business the ...